Dare Bioscience DARE
NASDAQ DARE
$0.65 -0.04 (-5.80%)
At close: Oct 22, 2026 · 4:00 PM EDT

Dare Bioscience (DARE) Amortization of Deferred Charges (2015 - 2025)

Updated

Analysis

Dare Bioscience (DARE) Amortization of Deferred Charges (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,142.35 Bn 1,110.94 Bn 19.71 Bn
2 Johnson & Johnson 635.52 Bn 555.38 Bn 17.30 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 356.35 Bn 310.72 Bn 12.21 Bn
5 Novartis Ag 300.53 Bn 264.52 Bn 11.24 Bn
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn
7 Amgen 238.00 Bn 193.40 Bn 7.24 Bn
8 Gilead Sciences 194.35 Bn 168.55 Bn 6.22 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn
10 Dare Bioscience 9.76 Mn -55.71 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 124,251.00
Jun 30, 2025 -5,910.00
Mar 31, 2025 17,532.00
Jun 30, 2024 21,216.00
Mar 31, 2024 659.00
Mar 31, 2017 610,000.00
Dec 31, 2016 85,000.00
Sep 30, 2016 93,000.00
Jun 30, 2016 115,000.00
Mar 31, 2016 127,000.00
Dec 31, 2015 -281,000.00
Sep 30, 2015 229,000.00
Jun 30, 2015 276,000.00
Mar 31, 2015 515,000.00
API Access

Dare Bioscience Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=DARE&period=max&api_key=YOUR_API_KEY